Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors
Brain serotonin-6 receptor (5-HT6R) is the one of the most recently identified serotonin receptors. Accumulating evidence suggests that it is a potent therapeutic target for psychiatric and neurological diseases. Since [18F]2FNQ1P was recently proposed as the first fluorinated positron emission tomo...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00471/full |
_version_ | 1818364591485222912 |
---|---|
author | Véronique Sgambato-Faure Véronique Sgambato-Faure Thierry Billard Thierry Billard Elise Météreau Elise Météreau Sandra Duperrier Sandra Duperrier Sylvain Fieux Sylvain Fieux Nicolas Costes Léon Tremblay Léon Tremblay Luc Zimmer Luc Zimmer Luc Zimmer Luc Zimmer |
author_facet | Véronique Sgambato-Faure Véronique Sgambato-Faure Thierry Billard Thierry Billard Elise Météreau Elise Météreau Sandra Duperrier Sandra Duperrier Sylvain Fieux Sylvain Fieux Nicolas Costes Léon Tremblay Léon Tremblay Luc Zimmer Luc Zimmer Luc Zimmer Luc Zimmer |
author_sort | Véronique Sgambato-Faure |
collection | DOAJ |
description | Brain serotonin-6 receptor (5-HT6R) is the one of the most recently identified serotonin receptors. Accumulating evidence suggests that it is a potent therapeutic target for psychiatric and neurological diseases. Since [18F]2FNQ1P was recently proposed as the first fluorinated positron emission tomography (PET) radioligand for this receptor, the objective of the present study was to demonstrate its suitability for 5-HT6R neuroimaging in primates. [18F]2FNQ1P was characterized by in vitro autoradiography and in vivo PET imaging in cynomolgus monkeys. Following in vivo PET imaging, tracer binding indices were computed using the simplified reference tissue model and Logan graphical model, with cerebellum as reference region. The tracer binding reproducibility was assessed by test–retest in five animals. Finally, specificity was assessed by pre-injection of a 5-HT6R antagonist, SB258585. In vitro, results showed wide cerebral distribution of the tracer with specificity toward 5-HT6Rs as binding was effectively displaced by SB258585. In vivo brain penetration was good with reproducible distribution at cortical and subcortical levels. The automated method gave the best spatial normalization. The Logan graphical model showed the best tracer binding indices, giving the highest magnitude, lowest standard deviation and best reproducibility and robustness. Finally, 5-HT6R antagonist pre-injection significantly decreased [18F]2FNQ1P binding mainly in the striatum and sensorimotor cortex. Taken together, these preclinical results show that [18F]2FNQ1P is a good candidate to address 5-HT6 receptors in clinical studies. |
first_indexed | 2024-12-13T22:06:48Z |
format | Article |
id | doaj.art-e7dc34cfcd90462aa22c95cde1c49215 |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-12-13T22:06:48Z |
publishDate | 2017-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-e7dc34cfcd90462aa22c95cde1c492152022-12-21T23:29:49ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-07-01810.3389/fphar.2017.00471275664Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 ReceptorsVéronique Sgambato-Faure0Véronique Sgambato-Faure1Thierry Billard2Thierry Billard3Elise Météreau4Elise Météreau5Sandra Duperrier6Sandra Duperrier7Sylvain Fieux8Sylvain Fieux9Nicolas Costes10Léon Tremblay11Léon Tremblay12Luc Zimmer13Luc Zimmer14Luc Zimmer15Luc Zimmer16Université Claude Bernard Lyon ILyon, FranceInstitut des Sciences Cognitives Marc Jeannerod, CNRS UMR5229Bron, FranceUniversité Claude Bernard Lyon ILyon, FranceInstitut de Chimie et de Biochimie, CNRS UMR5246Villeurbanne, FranceUniversité Claude Bernard Lyon ILyon, FranceInstitut des Sciences Cognitives Marc Jeannerod, CNRS UMR5229Bron, FranceUniversité Claude Bernard Lyon ILyon, FranceInstitut des Sciences Cognitives Marc Jeannerod, CNRS UMR5229Bron, FranceUniversité Claude Bernard Lyon ILyon, FranceCentre de Recherche en Neurosciences de Lyon, CNRS UMR5292, INSERM U1028Lyon, FranceCERMEP-Imagerie du VivantLyon, FranceUniversité Claude Bernard Lyon ILyon, FranceInstitut des Sciences Cognitives Marc Jeannerod, CNRS UMR5229Bron, FranceUniversité Claude Bernard Lyon ILyon, FranceCentre de Recherche en Neurosciences de Lyon, CNRS UMR5292, INSERM U1028Lyon, FranceCERMEP-Imagerie du VivantLyon, FranceHospices Civils de LyonLyon, FranceBrain serotonin-6 receptor (5-HT6R) is the one of the most recently identified serotonin receptors. Accumulating evidence suggests that it is a potent therapeutic target for psychiatric and neurological diseases. Since [18F]2FNQ1P was recently proposed as the first fluorinated positron emission tomography (PET) radioligand for this receptor, the objective of the present study was to demonstrate its suitability for 5-HT6R neuroimaging in primates. [18F]2FNQ1P was characterized by in vitro autoradiography and in vivo PET imaging in cynomolgus monkeys. Following in vivo PET imaging, tracer binding indices were computed using the simplified reference tissue model and Logan graphical model, with cerebellum as reference region. The tracer binding reproducibility was assessed by test–retest in five animals. Finally, specificity was assessed by pre-injection of a 5-HT6R antagonist, SB258585. In vitro, results showed wide cerebral distribution of the tracer with specificity toward 5-HT6Rs as binding was effectively displaced by SB258585. In vivo brain penetration was good with reproducible distribution at cortical and subcortical levels. The automated method gave the best spatial normalization. The Logan graphical model showed the best tracer binding indices, giving the highest magnitude, lowest standard deviation and best reproducibility and robustness. Finally, 5-HT6R antagonist pre-injection significantly decreased [18F]2FNQ1P binding mainly in the striatum and sensorimotor cortex. Taken together, these preclinical results show that [18F]2FNQ1P is a good candidate to address 5-HT6 receptors in clinical studies.http://journal.frontiersin.org/article/10.3389/fphar.2017.00471/fullPET imagingserotonin5-HT6 receptorstriatumnon-human primate |
spellingShingle | Véronique Sgambato-Faure Véronique Sgambato-Faure Thierry Billard Thierry Billard Elise Météreau Elise Météreau Sandra Duperrier Sandra Duperrier Sylvain Fieux Sylvain Fieux Nicolas Costes Léon Tremblay Léon Tremblay Luc Zimmer Luc Zimmer Luc Zimmer Luc Zimmer Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors Frontiers in Pharmacology PET imaging serotonin 5-HT6 receptor striatum non-human primate |
title | Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors |
title_full | Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors |
title_fullStr | Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors |
title_full_unstemmed | Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors |
title_short | Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors |
title_sort | characterization and reliability of 18f 2fnq1p in cynomolgus monkeys as a pet radiotracer for serotonin 5 ht6 receptors |
topic | PET imaging serotonin 5-HT6 receptor striatum non-human primate |
url | http://journal.frontiersin.org/article/10.3389/fphar.2017.00471/full |
work_keys_str_mv | AT veroniquesgambatofaure characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT veroniquesgambatofaure characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT thierrybillard characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT thierrybillard characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT elisemetereau characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT elisemetereau characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT sandraduperrier characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT sandraduperrier characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT sylvainfieux characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT sylvainfieux characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT nicolascostes characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT leontremblay characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT leontremblay characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT luczimmer characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT luczimmer characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT luczimmer characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors AT luczimmer characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors |